The Role of the Nurse in Chronic Disease Management in the COVID-19 Pandemic

Öz

COVID-19, which first appeared on December 31, 2019, in the city of Wuhan, Hubei province in China, has quickly become a global epidemic that causes a high number of deaths all over the world. COVID-19 generally manifested itself with symptoms such as high fever, weakness, cough in patients, and was more effective in people with advanced age and chronic diseases. Chronic diseases caused by more than one risk factor affect the immune system in various ways, reducing the quality of life of the person, and in this respect, it is an important risk factor for the course and course of the COVID-19 disease. For this reason, it is of great importance that the treatment and follow-up of patients with chronic diseases can be carried out without interruption during the pandemic. In this direction, public health nurses play a key role in the management of COVID-19 and chronic disease. The available literature on chronic disease management in the COVID-19 pandemic is limited. In the review, the most common chronic diseases associated with poor prognosis in the follow-up and mortality of Covid-19 are included. It is aimed to provide information about the chronic disease management in the COVID-19 pandemic and to contribute to the effective management of this process by nurses.

Anahtar Kelimeler

• COVID-19
• chronic disease
• nursing
• pandemic

COVID-19 Pandemisinde Kronik Hastalık Yönetiminde Hemşirenin Rolü

Öz

İlk kez 31 Aralık 2019’da Çin’de Hubei eyaleti Wuhan şehrinde ortaya çıkan COVID-19 kısa sürede tüm dünyada yüksek sayıda ölümlere neden olan küresel bir salgın haline gelmiştir. COVID-19, hastalarda genel olarak yüksek ateş, halsizlik, öksürük gibi belirtilerle kendini göstermiş, daha çok ileri yaş ve kronik rahatsızlığı olan kişilerde etkili olmuştur. Birden fazla risk faktörünün neden olduğu kronik hastalıklar, bağışıklık sistemini çeşitli yönlerden etkileyerek kişinin yaşam kalitesini düşürmekte bu yönüyle de COVID-19 hastalığının seyri ve gidişatı bakımından önemli bir risk faktörü olmaktadır. Bu nedenle pandemi süresince kronik hastalığı bulunan hastaların tedavi ve takiplerinin aksatılmadan yapılabilmesi büyük önem arz etmektedir. Bu doğrultuda halk sağlığı hemşireleri COVID-19 ve kronik hastalık yönetiminde anahtar rol oynamaktadır. COVID-19 pandemisinde kronik hastalık yönetiminde mevcut literatür sınırlıdır. Derlemede, Covid-19 izleminde ve mortalitesinde kötü prognozla ilişkili olan ve en çok görülen kronik hastalıklara yer verilmiştir. COVID-19 pandemisinde kronik hastalık yönetimi hakkında bilgi verilmesi ve hemşirelerin bu süreci etkin yönetebilmelerine katkı sağlaması amaçlanmıştır.

Anahtar Kelimeler

• COVID-19
• hemşirelik
• kronik hastalık
• pandemi

Kaynakça

1. Avcı, A., & Güdül, N.E. (2020). COVID-19 hastalarında kardiyovasküler değerlendirme. Türkiye Diyabet ve Obezite Dergisi, 4(2),147-154. https://doi.org/10.25048/tudod.737968
2. Akalu, Y., Ayelign, B., & Molla, M. D. (2020). Knowledge, attitude and practice towards COVID-19 among chronic disease patients at Addis Zemen Hospital, Northwest Ethiopia. Infection and Drug Resistance, 24(13),1949-1960. https://doi.org/10.2147/IDR.S258736
3. AlShamsi, H. O., Alhazzani, W., Alhuraiji, A., Coomes, E. A., Chemaly, R. F., Almuhanna, M., ... & Meyers, B. M. (2020). A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: an international collaborative group. The Oncologist, 25(6),936-945. https://doi.org/10.1634/theoncologist.2020-0213
4. Arslan, G., & Yelkuvan, İ. (2021). Covid-19, hipertansiyon ve hemşirelik bakımında önemli üç başlık: Fiziksel egzersiz, yeterli-dengeli beslenme, uyku. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi, 12(2), 531-536. https://doi.org/10.31067/acusaglik.852082
5. Avdal, E. Ü. (2020). COVID-19: Komorbid durumlarda bakım yönetimi. In F. Şenuzun Aykar (Ed.), İç Hastalıkları Hemşireliği ve COVID-19.(1.baskı, ss.10-14). Türkiye Klinikleri.
6. Brewster, D. J., Chrimes, N., Do, T. B., Fraser, K., Groombridge, C. J., Higgs, A., Humar, M.J., Leeuwenburg, T.J., McGloughlin, S., Newman, F.G., Nickson, C.P., Rehak, A., Vokes, D., & Gatward, J. J. (2020). Consensus statement: Safe Airway Society principles of airway management and tracheal intubation specific to the COVID-19 adult patient group. The Medical Journal of Australia, 212(10),472-481. https://doi.org/10.5694%2Fmja2.50598
7. Büyükkaya Besen, D., & Dervişoğlu, M. (2022). COVID-19 Salgınında diyabet yönetimi ve hemşirenin rolü. Gazi Sağlık Bilimleri Dergisi, 7(2), 78-89. https://doi.org/10.52881/gsbdergi.887427
8. Çöl, M., & Baysan, C. (2021). Kronik hastalıklar ve COVID-19. In M. Çöl (Ed.), Halk Sağlığı Bakışıyla COVID-19. (1. baskı, ss. 58-64). Türkiye Klinikleri.

9. D’Marco, L., Puchades, M. J., Romero-Parra, M., Gimenez-Civera, E., Soler, M. J., Ortiz, A., & Gorriz, J. L. (2020). Coronavirus disease 2019 in chronic kidney disease. Clinical Kidney Journal, 13(3), 297-306. https://doi.org/10.1093/ckj/sfaa104
10. Deitrick, K., Adams, J., & Davis, J. (2020). Emergency nursing care of patients with novel coronavirus disease 2019. The Journal of Emergency Nursing, 46(6), 748-59. https://doi.org/10.1016/j.jen.2020.07.010
11. Dorjee, K., Kim, H., Bonomo, E., & Dolma, R. (2020). Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients. PloS One, 15(12), e0243191. https://doi.org/10.1371/journal.pone.0243191
12. Dülger, Z., & Dönmez, E. (2021). COVID-19 ve kanser bakımı. Sağlık Akademisyenleri Dergisi, 8(3), 227-232.
13. Efil, S., & Enç, N. (2021). COVID-19’un solunumu sistemi üzerine etkileri ve Hemşirelik Bakımı. Yoğun Bakım Hemşireliği Dergisi, 25(2), 79-91.
14. Gabarre, P., Dumas, G., Dupont, T., Darmon, M., Azoulay, E., & Zafrani, L. (2020). Acute kidney injury in critically ill patients with COVID-19. Intensive Care Medicine, 46(7), 1339-1348. https://doi.org/10.1007/s00134-020-06153-9
15. Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., Wang, H., Wan, J., Wang, X., & Lu, Z. (2020). Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiology, 5(7), 811-818. https://doi.org/10.1001/jamacardio.2020.1017
16. Goicoechea, M., Cámara, L.A.S., Macías, N., de Morales, A.M., Rojas, Á.G., Bascunana, A., Arroyo, D., Vega, A., Abad, S., Verde, E., Prieto, A., Verdalles, U., Barbieri, D., Delgado, A., Carbayo, J., Mijaylova, A., Acosta, A., Melero, R. Tejjedor, A., … & Aragoncillo, I. (2020). COVID-19: Clinical course and outcomes of 36 hemodialysis patients in Spain. Kidney International, 98(1), 27-34. https://doi.org/10.1016/j.kint.2020.04.031
17. Goyal, P., Choi, J. J., Pinheiro, L. C., Schenck, E. J., Chen, R., Jabri, A., Satlin, M.J., Campion, T.R., Nahid, M., Ringel, J.B., Hoffman, K.L., Alshak, M.N., Li, H.A., Wehmeyer, G.T., Rajan, M., Reshetnyak, E., Hupert, N., Horn, E.M., Martinez, F.J., ... & Safford, M. M. (2020). Clinical characteristics of Covid-19 in New York city. New England Journal of Medicine, 382(24), 2372-2374. https://doi.org/10.1056/nejmc2010419
18. Hartmann-Boyce, J., Morris, E., Goyder, C., Kinton, J., Perring, J., Nunan, D., Mahtani, K.,Buse, J.,Prato, S.,Ji, L.,Roussel,R. & Khunti, K. (2020). Diabetes and COVID-19: risks, management, and learnings from other national disasters. Diabetes Care, 43(8), 1695-1703. https://doi.org/10.2337/dc20-1192
19. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., … Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223), 497-506. https://doi.org/10.1016/s0140-6736(20)30183-5
20. İncazlı, S. B., & Özer, S. (2021). COVID-19 sürecinde hipertansiyon hastaları için neler yapalım? Turkish Journal of Cardiovascular Nursing, 12(27), 52-58. https://doi.org/10.5543/khd.2021.90267
21. Karabacak, M. (2021). Covid-19 Pandemisinin kardiyovasküler etkileri. Süleyman Demirel Üniversitesi Tıp Fakültesi Dergisi, 28(COVID-19 Özel Sayısı), 229-233. https://doi.org/10.17343/sdutfd.915484
22. Lai, X. L., Wang, H. Y., & Guo, Z. Y. (2020). Recommendations for prevention and management of COVID-19 in peritoneal dialysis patients. Chronic Diseases and Translational Medicine, 6(02), 115-118. https://doi.org/10.1016/j.cdtm.2020.04.003
23. Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K.S.M., Lau, E.H.Y., Wong, J.Y., Xing, X., Xiang, N., Wu, Y., Li, C., Chen, Q., Li, D., Liu, T., Zhao, J., Liu, M., ... & Feng, Z. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England Journal Of Medicine, 382(13), 1199-1207. https://doi.org/10.1056/NEJMoa2001316 Liang, T. (2020, November 15). Handbook of COVID-19 Prevention and Treatment. https://www.researchgate.net/publication/339998871_Handbook_of_COVID-19_Prevention_ and_Treatment
24. Liang, W., Guan, W., Chen, R., Wang, W., Li, J., Xu, K., Li, C., Ai, Q.,Lu, W.,Liang, H.,Li, S., & He, J. (2020). Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. The Lancet Oncology, 21(3), 335-337. https://doi.org/10.1016/S1470-2045(20)30096-6
25. Luo, Y., Li, J., Liu, Z., Yu, H., & Peng, X. (2020). Characteristics and outcomes of hemodialysis patients with covıd-19: a retrospective single center study. Peerj, 8, E10459. https://doi.org/10.7717/peerj.10459
26. Madjid, M., Safavi-Naeini, P., Solomon, S. D., & Vardeny, O. (2020). Potential effects of coronaviruses on the cardiovascular system: a review. Journal of the American Medical Association Cardiology, 5(7), 831-840. https://doi.org/10.1001/jamacardio.2020.1286
27. Mantovani, A., Byrne, C. D., Zheng, M. H., & Targher, G. (2020). Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: a meta-analysis of observational studies. Nutrition, Metabolism and Cardiovascular Diseases, 30(8), 1236-1248. https://doi.org/10.1016/j.numecd
28. Mao, B., Liu, Y., Chai, Y. H., Jin, X. Y., Lu, H. W., Yang, J. W., Gao, X. W., Song, X. L., Bao, H., Wang, A., Gu, W. C., Zhao, L., Pan, J. P., Li, F., Zhang, T. F., Qian, Y. C., Du, C. L., Ding, W., Tu, C. L., ... & Xu, J. F. (2020). Assessing risk factors for SARS-CoV-2 infection in patients presenting with symptoms in Shanghai, China: a multicentre, observational cohort study. The Lancet Digital Health, 2(6), e323-e330. https://doi.org/10.1016/s2589-7500(20)30109-6
29. Mills, K. T., Stefanescu, A., & He, J. (2020). The global epidemiology of hypertension. Nature Reviews Nephrology, 16(4), 223-237. https://doi.org/10.1038/s41581-019-0244-2
30. Mishra, P., Parveen, R., Bajpai, R., Samim, M., & Agarwal, N. B. (2021). Impact of cardiovascular diseases on severity of COVID-19 patients: A systematic review. Annals Academy of Medicine Singapore, 50(1), 52-60. https://doi.org/10.47102/annals-acadmedsg.2020367
31. Özdemir, S. T. (2021). Covid-19 pandemisi ve kronik böbrek hastalarına etkisi. Nefroloji Hemşireliği Dergisi,16(2), 60-66. https://doi.org/10.47565/ndthdt.2021.33
32. Pina, A., & Castelletti, S. (2021). COVID-19 and cardiovascular disease: A global perspective. Current Cardiology Reports, 23(10), 1-7. https://doi.org/10.1007/s11886-021-01566-4
33. Pranata, R., Henrina, J., Raffaello, W. M., Lawrensia, S., & Huang, I. (2021). Diabetes and COVID-19: the past, the present, and the future. Metabolism, 121 (2021),154814. https://doi.org/10.1016/j.metabol.2021.154814
34. Roncon, L., Zuin, M., Zuliani, G., & Rigatelli, G. (2020). Patients with arterial hypertension and COVID-19 are at higher risk of ICU admission. British Journal of Anaesthesia, 125(2), e254-e255. https://doi.org/10.1016/j.bja.2020.04.056
35. Sağlık Bakanlığı. (2020). (2022, November 20). COVID-19 (SARS-CoV-2 Enfeksiyonu) Rehberi. https://covid19bilgi.saglik.gov.tr/tr/
36. Sandalcı, B., Uyaroğlu, O. A., & Güven, G. S. (2020). COVID-19’da kronik hastalıkların rolü, önemi ve öneriler. Flora, 25(5), 1-7. https://doi.org/10.5578/flora.69700.
37. Sharma, S. K., Nuttall, C., & Kalyani, V. (2020). Clinical nursing care guidance for management of patient with COVID-19. JPMA. The Journal of the Pakistan Medical Association, 70(5), 118-123. https://doi.org/10.5455/jpma.29
38. Shuman, A. G., & Pentz, R. D. (2020). Cancer research ethics and COVID‐19. The Oncologist, 25(6), 458-459. https://doi.org/10.1634/theoncologist.2020-0221
39. Sofulu, F., Uran, B. Ö., Avdal, E. Ü., & Tokem, Y. (2020). COVID-19 salgınında kronik hastalıklarda hemşirelik yönetimi. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi, 5(2), 147-151.
40. Taşkaldıran, I., & Bayraktaroğlu, T. (2020). COVID-19 ve hipertansiyon. Türkiye Diyabet ve Obezite Dergisi, 4(2), 155-159. http://doi.org/10.25048/tudod.752989
41. Tortonese, S., Scriabine, I., Anjou, L., Loens, C., Michon, A., Benabdelhak, M., Ouali, S., Morin, G., Laifi, M., Dobosziewicz, H., Guillet, M., Dekeyser, M., Luong Nguyen, L. B., Grünenwald, A., Dang, J., Desbuissons, G., Becquemont, L., Snanoudj, R., Legendre, C., … & AP-HP/Universities/Inserm COVID-19 research collaboration. (2020). COVID-19 in patients on maintenance dialysis in the Paris region. Kidney International Reports, 5(9), 1535-1544. https://doi.org/10.1016/j.ekir.2020.07.016
42. Wang, X., Fang, X., Cai, Z., Wu, X., Gao, X., Min, J., & Wang, F. (2020). Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: a systemic review and meta-analysis. Research (Washington D.C.), 2020, 2402961. https://doi.org/10.34133/2020/2402961
43. Williams, R., Karuranga, S., Malanda, B., Saeedi, P., Basit, A., & Besançon, S. (2020). Global and regional estimates and projections of diabetes-related health expenditure: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Research and Clinical Practice, 162, 108072. https://doi.org/10.1016/j.diabres.2020.108072
44. Xie, J., Tong, Z., Guan, X., Du, B., & Qiu, H. (2020). Clinical characteristics of patients who died of coronavirus disease 2019 in China. JAMA Network Open, 3(4), e205619-e205619. https://doi.org/10.1001/jamanetworkopen.2020.5619
45. Xiong, F., Tang, H., Liu, L., Tu, C., Tian, J. B., Lei, C. T., Liu, J., Dong, J. W., Chen, W. L., Wang, X. H., Luo, D., Shi, M., Miao, X. P., & Zhang, C. (2020). Clinical characteristics of and medical interventions for covıd-19 in hemodialysis patients in Wuhan, China. Journal of The American Society of Nephrology. 31(7), 1387–1397. https://doi.org/10.1681/ASN.2020030354
46. Ünal, Ç., & Güçlüel, Ö.Y. (2022). COVID-19 tanısı alan ve Diabetes Mellitus hastalığı olan hastanın Orem’in öz bakım kuramına göre evde hemşirelik bakımı: Olgu sunumu. Türk Diyabet Hemşireliği Dergisi,2(2), 37-41. http://dx.doi.org/10.29228/tjdn.67682
47. Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020). Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis. International Journal of Infectious Diseases, 94, 91-95. https://doi.org/10.1016/j.ijid.2020.03.017
48. Yücel, E., & Tamay, Z. (2020). Astım ve COVID-19. Çocuk Dergisi, 20(2),76-79. https://doi.org/10.26650/jchild.2020.2.738379
49. Yüksel, S. (2020). Sağlıklı yaşam biçimi ddavranışları. Spor ve Rekreasyon Araştırmaları Dergisi, 2(1), 34-43.
50. Zhao, Q., Meng, M., Kumar, R., Wu, Y., Huang, J., Lian, N., Deng, Y., & Lin, S. (2020). The impact of COPD and smoking history on the severity of COVID‐19: A systemic review and meta‐analysis. Journal of Medical Virology, 92(10), 1915-1921. https://doi.org/10.1002/jmv.25889
51. Zhou, Y., Yang, Q., Chi, J., Dong, B., Lv, W., Shen, L., & Wang, Y. (2020). Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis. International Journal of Infectious Diseases, 99, 47-56. https://doi.org/10.1016/j.ijid.2020.07.029